#We Believe in Science
OUR CLINICAL STUDIES PUBLISHED AT Q1, Q2, Q3 LEVELS
Our study on Kiperin Double Hydrolyzed Collagen Peptide formulation has been published in Cellular and Molecular Biology Letters journal, a Q3 level journal based in Basel, Switzerland. The study scientifically demonstrated the biological effects of the formulation evaluated at the cellular level and its potential on antioxidant response.
Our study on Kiperin Postbiotic formulation has been published in the high impact factor Q1 level Biomedicines journal based in Switzerland. The study scientifically demonstrated our positive effects on fibroblast functions, oxidative stress and immune genes.
OUR ETHICS COMMITTEE APPROVALS
Ethics Committee Approval for Clinical Study Investigating the Effects of Type 1 and Type 3 Collagen Use on Quality of Life through Survey
Ethics Committee Approval for the Effects of Mind-Focus Supplement on Brain and Behavior in Animal Model
Ethics Committee Approval for Cell Culture Study with Purple Collagen in Normal and Cancer Cell Lines
Ethics Committee Approval for the Effects of Postbiotic Supplement in Cell Culture
Ethics Committee Approval for Cell Culture Study with Classic Collagen in Normal and Cancer Cell Lines
Ethics Committee Approval for the Study Investigating the Effects of Cranberry Supplement in Cell Culture
Ethics Committee Approval for the Study Evaluating the Effects of Magnesium Supplement in Cell Culture
Ethics Committee Approval for Clinical Effects of Collagen Supplement on Knee Cartilage Health
Ethics Committee Approval for Dermatology Study on Clinical Effects of Collagen Supplement on Skin Health
Animal Experiment Ethics Committee Approval for Collagen and Purple Collagen Studies
×
![]()